ÂÜÀòÂÒÂ×

Matt Kelly is an accomplished healthcare executive with extensive experience in innovation and clinical strategy. Currently serving as Head of IP and Clinical Strategy at Caristo Diagnostics since August 2023, Matt previously held significant positions at Perspectum Diagnostics Ltd, including Chief Innovation Officer and Head of Innovation, where responsibilities included defining and executing product roadmaps and leading teams to explore clinical opportunities. Prior to that, Matt worked at Siemens Molecular Imaging in various roles, including Senior Key Expert and Senior Staff Scientist, focusing on technology development in clinical data analytics and oncology imaging. With a Ph.D. in Computational Drug Design from the University of Cambridge and a B.Sc. in Applied Neuroscience from The University of Manchester, Matt's background combines scientific research with strategic leadership in the healthcare sector.